Baylor College of Medicine: NCI-COG Pediatric MATCH Study Shows Benefit Of Genetic Screening in Refractory Tumors
April 05, 2022
April 05, 2022
HOUSTON, Texas, April 5 (TNSJou) -- The Baylor College of Medicine issued the following news:
Cancer therapies targeting specific genetic mutations may offer benefits to patients for whom other standard chemotherapy treatments have not effectively treated their tumor. However, genetic screening of tumors is not routinely performed for pediatric and young adult cancer patients. To increase access to tumor genetic screening and study the utility of this strategy, the National Cancer I . . .
Cancer therapies targeting specific genetic mutations may offer benefits to patients for whom other standard chemotherapy treatments have not effectively treated their tumor. However, genetic screening of tumors is not routinely performed for pediatric and young adult cancer patients. To increase access to tumor genetic screening and study the utility of this strategy, the National Cancer I . . .